CannabisNewsBreaks Archive - Page 402 of 405

WednesdayApr 05, 2017 10:11 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Announces Sale of Brilliant Hallmark Stake

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the sale of its investment interest in Brilliant Hallmark for a consideration of four million shares of IGC. The shares, which were previously issued to Brilliant Hallmark on August 4, 2016, will be returned and retired, while the Brilliant Hallmark investment will be removed from the company's balance sheet with an associated reduction of roughly $1.88 million. Per this morning’s update, IGC does not expect to record a gain or loss from this transaction. “This strategic move is…

TuesdayApr 04, 2017 3:50 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (IMLFF) Takes Aim at Rare Skin Diseases with INM-750

Epidermolysis bullosa (EBS) is a group of rare inherited skin diseases that unfortunately have no currently approved or known cure or treatment. InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has developed INM-750 as the first therapy to specifically treat EBS. “Earlier this month, InMed filed an international Patent Cooperation Treaty application for intellectual and commercial protection of INM-750 and a cannabinoid-based therapy for EBS. This marks a significant milestone for the company, serving as validation for its efforts to develop new therapies based on cannabinoids and its unique approach to drug development. The company is using a proprietary bioinformatics assessment tool to…

ThursdayMar 30, 2017 11:13 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Invests in Breakwater MB, LLC

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company formed by CIIX board member and former CFO Paul Dickman. CIIX’s initial investment into Breakwater MB will total $250,000, with the company maintaining an option to make additional investments at its own election. Per the news release, Breakwater MB intends to use the invested capital primarily to cover the costs of becoming a publicly traded company. CIIX management expects that this strategy will provide significant investment appreciate and opportunity for liquidity. “With the gradual opening up of the…

WednesdayMar 29, 2017 11:10 am

CannabisNewsBreaks – Players Network, Inc. (PNTV) Presenting at America First Investment Luncheon on March 31, 2017

Players Network’s (OTCQB: PNTV) CEO Mark Bradley and Director Brett H. Pojunis are set to present at the "America First Investment" financial luncheon hosted by ClubsCorp Business Network in Las Vegas on March 31, 2017, from 12:30-3:00 p.m. PDT. The diversified holding company was invited to present at the luncheon series that features select emerging companies who will present to attending investment bankers, institutional investors, and individual accredited investors. In addition to the presentation, both Bradley and Pojunis will be available for one-on-one meetings with investors. To register visit: https://goo.gl/gnkPRJ To view the full press release, visit: http://nnw.fm/Z3TrT About Players…

ThursdayMar 23, 2017 9:38 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Audio Interview with CannabisNewsWire

Multifaceted financial news and publishing company CannabisNewsWire this morning announced the online availability of a new audio interview with India Globalization Capital, Inc. (NYSE MKT: IGC) CEO Ram Mukunda. In the interview, Mukunda discusses IGC’s operations and targeted market, as well as leading formulations currently in the company’s development pipeline. “This is a very exciting time for us, an exciting opportunity,” Mukunda noted in the interview. “We believe that we have first-mover advantage in combination therapy, as very few companies are actually working on cannabis-based pharmaceuticals and within that space we believe that we are the only ones working on…

WednesdayMar 22, 2017 2:38 pm

CannabisNewsBreaks – InMed Pharmaceuticals (IMLFF) Featured in Forbes Article Discussing Unique Cannabinoid Manufacturing System and Database

InMed Pharmaceuticals (OTCQB: IMLFF) was recently featured in a Forbes article highlighting the company's cannabinoid manufacturing system and database, which is used to map different compounds of cannabinoids to the various diseases they are able to treat. According to the article, InMed’s database appeals to other biotech companies who are now willing to purchase the information. Using its database, InMed has been able to identify two new cannabinoid therapies. Additionally, the company has created a method of biosynthesis for cannabinoids that is comparable to the system used to create synthetic insulin for diabetic patients. The company begins with the cannabinoid…

TuesdayMar 21, 2017 9:58 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Files Provisional Patent for Treatment of Eating Disorders Using Cannabis Extracts

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds. Should this filing result in the issuance of a patent, IGC intends to develop its IGC-506 candidate for both human and veterinary use. “The development of cannabis-based combination therapies represents a large, unique opportunity, and we believe we are the first mover in this emerging specialty-pharmaceutical sector,” Ram Mukunda, chief executive officer…

ThursdayMar 16, 2017 12:35 pm

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article

India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company's strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore. That focus changed a few years ago when iron ore prices plummeted, often selling below its cost of production. For the last three years, the company has shifted its focus to tackling the cannabis industry, or more specifically, medical cannabis use. The company is currently developing a portfolio to address epilepsy, cachexia, PTSD, Alzheimer’s, and Parkinson’s. “We came up…

ThursdayMar 16, 2017 10:40 am

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Announces Engagement of CannabisNewsWire

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) this morning announced its engagement of CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging an investor-based distribution network that includes more than 5,000 key syndication outlets, various newsletters, numerous social media channels, blogs, and other outreach tools, CNW will look to generate greater brand awareness for Player’s Network as the company seeks to expand its presence in both the media and cannabis industries. “This partnership is an extension of our new shareholder…

WednesdayMar 15, 2017 4:23 pm

CannabisNewsBreaks – Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth

As the medical marijuana market continues to grow, so does the number of biotech companies expanding their research into the development of innovative cannabinoid-based pharmaceuticals and delivery systems. It is estimated that the U.S. consumer market for cannabinoid pharmaceuticals will increase exponentially in upcoming years, exceeding $50 billion by 2029, according to Statista. This doesn’t appear to be a lofty forecast, given the prominence this market segment has gained by the sustained efforts and innovations of leading biotech companies such as InMed Pharmaceuticals, Inc. (IMLFF) (InMed Profile), GW Pharmaceuticals plc (GWPH), Zynerba Pharmaceuticals, Inc. (ZYNE), AXIM® Biotechnologies, Inc. (AXIM) and…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks